Mitochondrial transplantation as a next-generation therapeutic for COPD
Description: Artificial mitochondria transplantation (AMT) is a cutting-edge therapy that refers to the transplantation of healthy mitochondria to damaged cells to aid in recovery. Current techniques rely on the transplantation of stem cells, which poses major risks, such as tumorigenicity. We have developed an innovative mitochondria transplantation technique that utilizes extracellular vesicles (EVs) as a carrier for targeted mitochondria delivery (Mito-EVs) and will test this therapy in lung disease.
Amount: A$885,200
Funding type: research
Funder scheme: Ideas Grants - 2024 Ideas Grants
Investigator: Wojciech Chrzanowski
Institution: University of Sydney
Funded outputs count: 3
Funder award ID: 2037119
OpenAlex ID: G4714947553